Chandler J. Bronkema, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenocarcinoma | 2 | 2020 | 6364 | 0.410 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 11083 | 0.370 |
Why?
|
| Cystitis | 1 | 2023 | 96 | 0.210 |
Why?
|
| Inpatients | 2 | 2023 | 2564 | 0.190 |
Why?
|
| Seminal Vesicles | 1 | 2021 | 101 | 0.180 |
Why?
|
| Kidney Cortex | 1 | 2020 | 167 | 0.170 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2020 | 66 | 0.170 |
Why?
|
| Survival Rate | 4 | 2022 | 12795 | 0.160 |
Why?
|
| Carcinoma, Ductal | 1 | 2020 | 97 | 0.160 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2020 | 80 | 0.160 |
Why?
|
| Carcinosarcoma | 1 | 2020 | 106 | 0.160 |
Why?
|
| Cystectomy | 2 | 2022 | 604 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2022 | 2176 | 0.150 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2020 | 521 | 0.130 |
Why?
|
| Nephrectomy | 1 | 2020 | 927 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2020 | 8067 | 0.120 |
Why?
|
| Hypogonadism | 1 | 2020 | 801 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2023 | 2464 | 0.110 |
Why?
|
| Prostatectomy | 1 | 2021 | 1782 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3454 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2023 | 15747 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 2178 | 0.070 |
Why?
|
| United States | 4 | 2023 | 72903 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11206 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4274 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2022 | 3602 | 0.050 |
Why?
|
| Male | 10 | 2023 | 363698 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2022 | 88 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2023 | 81514 | 0.050 |
Why?
|
| Aged | 6 | 2023 | 171117 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 59489 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2023 | 1158 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2023 | 956 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2023 | 1247 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 765968 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 629 | 0.030 |
Why?
|
| Middle Aged | 5 | 2022 | 223009 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 753 | 0.030 |
Why?
|
| Incidence | 2 | 2023 | 21480 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 2233 | 0.020 |
Why?
|
| Decision Making | 1 | 2023 | 3965 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 3230 | 0.020 |
Why?
|
| Testosterone | 1 | 2020 | 2494 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 3236 | 0.020 |
Why?
|
| Length of Stay | 1 | 2023 | 6485 | 0.020 |
Why?
|
| Mass Screening | 1 | 2023 | 5446 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3835 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9373 | 0.010 |
Why?
|
| Female | 4 | 2023 | 396112 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29922 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39193 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 65188 | 0.010 |
Why?
|